Trial Profile
Bepridil in patients with persistent atrial fibrillation and endothelial dysfunction.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Bepridil (Primary)
- Indications Atrial fibrillation
- Focus Pharmacodynamics